Literature DB >> 10101680

The role of CTLA-4 in the regulation of T cell immune responses.

K D McCoy1, G Le Gros.   

Abstract

Over the past few years a great deal of research has examined how T cell-dependent immune responses are initiated and subsequently regulated. Ligation of the TCR with an antigenic peptide bound to an MHC protein on a professional APC provides the crucial antigen-specific stimulus required for T cell activation. Interaction of CD28 with CD80 or CD86 molecules on APC initiates a costimulatory or second signal within the T cell which augments and sustains T cell activation initiated through the TCR. However, recently it has become clear that T cell immune responses are a result of a balance between stimulatory and inhibitory signals. Cytotoxic T lymphocyte-associated molecule-4 (CTLA-4) is a cell surface molecule that is expressed nearly exclusively on CD4+ and CD8+ T cells. Investigation into the role of CTLA-4 in the regulation of T cell immune responses has revealed that CTLA-4 is a very important molecule involved in the maintenance of T cell homeostasis. In the present review, evidence for the proposed inhibitory role of CTLA-4 is examined and a model suggesting a role for CTLA-4 in both early and late stages of T cell activation is presented.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10101680     DOI: 10.1046/j.1440-1711.1999.00795.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  77 in total

Review 1.  Experimental corneal allograft rejection.

Authors:  Bryan M Gebhardt; Weiyun Shi
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Polymorphisms in the CTLA-4 gene and rheumatoid arthritis susceptibility: a meta-analysis.

Authors:  Xiaobo Li; Cong Zhang; Jie Zhang; Yonggang Zhang; Zhangjun Wu; Lian Yang; Zhangpeng Xiang; Zhanzhong Qi; Xin Zhang; Xingqiong Xiao
Journal:  J Clin Immunol       Date:  2012-02-23       Impact factor: 8.317

Review 3.  Immune modulating peptides for the treatment and suppression of multiple sclerosis.

Authors:  Ahmed H Badawi; Teruna J Siahaan
Journal:  Clin Immunol       Date:  2012-06-05       Impact factor: 3.969

4.  Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.

Authors:  Max A Cheng; Emily Farmer; Claire Huang; John Lin; Chien-Fu Hung; T-C Wu
Journal:  Hum Gene Ther       Date:  2018-03-16       Impact factor: 5.695

5.  Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.

Authors:  Leila Ksiaa Cheikhrouhou; Yousr Lakhoua-Gorgi; Imen Sfar; Salwa Jendoubi-Ayed; Houda Aouadi; Mouna Makhlouf; Khaled Ayed; Taieb Ben Abdallah
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

6.  Renal release of N-acetyl-seryl-aspartyl-lysyl-proline is part of an antifibrotic peptidergic system in the kidney.

Authors:  Cesar A Romero; Nitin Kumar; Pablo Nakagawa; Morel E Worou; Tang-Dong Liao; Edward L Peterson; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2018-11-07

Review 7.  Restoring Regulatory T Cells in Type 1 Diabetes.

Authors:  Allyson Spence; Qizhi Tang
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

Review 8.  Melanoma immunotherapy dominates the field.

Authors:  Panagiotis Diamantopoulos; Helen Gogas
Journal:  Ann Transl Med       Date:  2016-07

9.  CTLA-4 blockade: therapeutic potential in cancer treatments.

Authors:  Ahmad A Tarhini; Fatima Iqbal
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

10.  CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer.

Authors:  Fee Bengsch; Dawson M Knoblock; Anni Liu; Florencia McAllister; Gregory L Beatty
Journal:  Cancer Immunol Immunother       Date:  2017-08-30       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.